My title

Albumin and surgical site infection risk in orthopaedics: meta-analysis

by jmiller on May 16, 2017

This article (BMC Surgery, April), concludes “that the meta-analysis demonstrated that an albumin level <3.5 g/dl had an almost 2.5 fold increased risk of SSI in orthopaedics,   Click here to read full-text.… learn more

Screening for thyroid cancer: USPSTF Recommendation Statement

by jmiller on May 16, 2017

The article concludes:  “The USPSTF recommends against screening for thyroid cancer in asymptomatic adults.”  (JAMA, May 9)  Click here to read full text.… learn more

In the news: Risk of acute myocardial infarction with NSAIDS in real world use: bayesian meta-analysis of individual patient data

by jmiller on May 16, 2017

What this study adds:   (BMJ, May 3)  “Using a Bayesian meta-analysis of individual patient data and studying real world settings, it is shown that all traditional NSAIDS, including naproxen, appear to be associated with an increased risk of acute myocardial … learn more

Collaborative Care Network Update

by Medical Staff Office on April 19, 2017

Chaired by Robert Hanley, MD, of Anne Arundel Urology, the Collaborative Care Network (CCN) is our local, physician-led platform that allows the health system to join forces with independent and employed physicians to share data, resources and opportunities to improve … learn more

In the news: A 12-week cycling training regimen improves gait and executive functions concomitantly in people with Parkinson’s disease

by jmiller on April 13, 2017

“AET (aerobic exercise training) using stationary bicycle can independently improve gait and cognitive inhibition in sedentary PD patients.  Given that increases in walking speed were obtained through increases in cadence, with no change in step length, our findings support that … learn more

“Increase in the inceidence of diabetes and its implications”; “Incidence trends of type 1and type 2 diabetes among youths, 2002-2012″ and “Mortality and cardiovascular disease in Type 1 and Type 2 diabetes”

by jmiller on April 13, 2017

These three articles are inter-related (NEJM Apr 13).  “Although it is not surprising that the incidence of type 2 diabetes among youths is increasing, the differing rates among racial and ethnic groups is somewhat unexpected.  The authors note that some … learn more

Who decides when a patient can’t? Statutes on alternate decision makers

by jmiller on April 13, 2017

“The estimated prevalence of decisional incapacity approaches 40% among adult medical inpatients and residential hospice patients and exceeds 90% among adults in some intensive care units.  Unfortunately, the rate of completion of advance directives in the general U.S. population hovers … learn more

In the news: Ocrevus (Ocrelizumab) approved by the FDA for Multiple Sclerosis

by jmiller on March 30, 2017

Ocrelizumab was just approved by the FDA for treating multiple sclerosis.  The New England Journal of Medicine (Jan 19) published “Ocrelizumab versus placebo in primary progressive multiple sclerosis” concluding “among patients with primary progressive multiple sclerosis, ocrelizumab was associated with … learn more

Older posts «

» Newer posts